Publication: 2371

Publication: 2371

Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance)

DOI

URL

Google Scholar

Citation:: Cancer Res vol 76 (4 Suppl) S2-05

Meeting Instance:: SABCS 2015
Year:: 2016
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3429 3660

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:: William M Sikov
Authors:: William M Sikov Donald A Berry Charles M Perou Baljit Singh Constance T Cirrincione Sara M Tolaney Charles S Kuzma Timothy J Pluard George Somlo Elisa R Port Mehra Golshan Jennifer R Bellon Deborah Collyar Olwen M Hahn Lisa A Carey Clifford A Hudis Eric P Winer

Networks:: CA043, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR

Study: CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: